IL3 and chronic myelogenous leukemia, BCR-ABL1 positive: For example, interleukin-3 (IL-3) expressed on the surface of EVs can be used to target the delivery of EVs to the IL-3 receptor that is highly expressed in chronic myelogenous leukemia cells compared with that in normal hematopoietic cells (67).